Bank OZK (OZK) Cash Flow Statement

Operating cash flow has consistently exceeded net income, with OCF/NI ratios ranging from 0.80x to 1.56x over the last ten quarters. The 2026Q2 ratio of 1.22x reflects efficient conversion of earnings to cash, driven by non-cash provisions and depreciation. This internal capital generation supports the bank's ability to maintain regulatory capital ratios while expanding its loan book, reducing the need for dilutive equity issuance.

The investment portfolio activity has been volatile, with net purchases swinging from $366.5M in 2026Q2 to net sales of $144.8M in 2025Q2. This pattern indicates active balance sheet management, likely to optimize yields and manage duration. The recent increase in purchases may reflect reinvestment of maturing securities or deployment of deposit inflows, but investors should monitor whether this signals a shift toward longer-duration assets that could increase AOCI sensitivity.

The cash flow statement does not separately disclose loan originations, but the balance sheet trend indicates decelerating loan growth, consistent with the 1.1% revenue growth in 2026Q2. The bank's ability to fund loans is tied to its deposit base, which remains granular and low-cost. However, the rising cost of interest-bearing deposits, as noted in prior analysis, may be limiting the bank's ability to price new loans competitively, potentially slowing future origination volumes.

Dividends have increased steadily each quarter, from $47.1M in 2024Q1 to $55.5M in 2026Q2, a 17.8% cumulative increase. Buybacks have been sporadic, with notable activity only in 2025Q4 ($93.7M) and 2026Q1 ($60.0M). The dividend payout ratio, based on net income, is approximately 33%, leaving ample room for retention. This capital return strategy aligns with the bank's historical pattern of consistent dividend increases, but investors should monitor whether buybacks resume given the decelerating growth outlook.

The cash flow statement does not directly show deposit flows, but the income statement reveals NIM compression from 1.1% to 0.9% over two years. This indicates that deposit costs are rising faster than loan yields, reducing the spread that drives operating cash flow. The bank's low-cost deposit base in the Southeast provides some cushion, but the recent trend suggests that competitive pressures are eroding this advantage. Investors should monitor deposit beta trends, as further increases could dampen future cash generation.

The provision for credit losses has trended upward, from $35.2M in 2025Q2 to $45.6M in 2026Q2, indicating a more cautious credit stance. This aligns with the shift in RESG portfolio mix toward life sciences and medical office buildings, which may carry different risk profiles. The fact that charge-offs are not disclosed in the cash flow data suggests they are immaterial, but the rising provisions imply management expects higher losses in the future. This could pressure future earnings and cash flows if the economic outlook deteriorates.